BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12897064)

  • 41. Characterization of rat C5a anaphylatoxin receptor (C5aR): cloning of rat C5aR cDNA and study of C5aR expression by rat astrocytes.
    Sayah S; Patte C; Gasque P; Chan P; Ischenko A; Vaudry H; Fontaine M
    Brain Res Mol Brain Res; 1997 Sep; 48(2):215-22. PubMed ID: 9332718
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of C5a in inflammatory responses.
    Guo RF; Ward PA
    Annu Rev Immunol; 2005; 23():821-52. PubMed ID: 15771587
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The harmful role of c5a on innate immunity in sepsis.
    Ward PA
    J Innate Immun; 2010; 2(5):439-45. PubMed ID: 20588003
    [TBL] [Abstract][Full Text] [Related]  

  • 44. C5a receptor-mediated production of IL-8 by the human retinal pigment epithelial cell line, ARPE-19.
    Fukuoka Y; Medof EM
    Curr Eye Res; 2001 Nov; 23(5):320-5. PubMed ID: 11910520
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distinct neutrophil C5a receptor inflammatory events in cows initiated by chemoattractant C5a and lipopolysaccharide around parturition and in mid lactation.
    Boulougouris X; Rogiers C; Van Poucke M; De Spiegeleer B; Peelman LJ; Duchateau L; Burvenich C
    J Dairy Sci; 2019 Feb; 102(2):1457-1472. PubMed ID: 30594380
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment with anti-C5aR mAb leads to early-onset clinical and mechanistic effects in the murine delayed-type hypersensitivity arthritis model.
    Atkinson SM; Nansen A; Usher PA; Sondergaard BC; Mackay CR; Friedrichsen B; Chang CC; Tang R; Skov S; Haase C; Hornum L
    Autoimmunity; 2015; 48(7):460-70. PubMed ID: 25915570
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of C5a receptor by monoclonal antibody.
    Watanabe H; Kuraya M; Kasukawa R; Yanagisawa H; Yanagisawa M; Fujita T
    J Immunol Methods; 1995 Sep; 185(1):19-29. PubMed ID: 7665898
    [TBL] [Abstract][Full Text] [Related]  

  • 48. C5L2: a controversial receptor of complement anaphylatoxin, C5a.
    Li R; Coulthard LG; Wu MC; Taylor SM; Woodruff TM
    FASEB J; 2013 Mar; 27(3):855-64. PubMed ID: 23239822
    [TBL] [Abstract][Full Text] [Related]  

  • 49. cDNA cloning and characterization of rat C5a anaphylatoxin receptor.
    Akatsu H; Miwa T; Sakurada C; Fukuoka Y; Ember JA; Yamamoto T; Hugli TE; Okada H
    Microbiol Immunol; 1997; 41(7):575-80. PubMed ID: 9272704
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Complement C5a Functions as a Master Switch for the pH Balance in Neutrophils Exerting Fundamental Immunometabolic Effects.
    Denk S; Neher MD; Messerer DAC; Wiegner R; Nilsson B; Rittirsch D; Nilsson-Ekdahl K; Weckbach S; Ignatius A; Kalbitz M; Gebhard F; Weiss ME; Vogt J; Radermacher P; Köhl J; Lambris JD; Huber-Lang MS
    J Immunol; 2017 Jun; 198(12):4846-4854. PubMed ID: 28490576
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The interaction between C5a and both C5aR and C5L2 receptors is required for production of G-CSF during acute inflammation.
    Bosmann M; Haggadone MD; Zetoune FS; Sarma JV; Ward PA
    Eur J Immunol; 2013 Jul; 43(7):1907-13. PubMed ID: 23575697
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sulfated tyrosines contribute to the formation of the C5a docking site of the human C5a anaphylatoxin receptor.
    Farzan M; Schnitzler CE; Vasilieva N; Leung D; Kuhn J; Gerard C; Gerard NP; Choe H
    J Exp Med; 2001 May; 193(9):1059-66. PubMed ID: 11342590
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulatory role of C5a on macrophage migration inhibitory factor release from neutrophils.
    Riedemann NC; Guo RF; Gao H; Sun L; Hoesel M; Hollmann TJ; Wetsel RA; Zetoune FS; Ward PA
    J Immunol; 2004 Jul; 173(2):1355-9. PubMed ID: 15240730
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression and modulation of C5a receptor (CD88) on skin dendritic cells. Chemotactic effect of C5a on skin migratory dendritic cells.
    Morelli A; Larregina A; Chuluyán I; Kolkowski E; Fainboim L
    Immunology; 1996 Sep; 89(1):126-34. PubMed ID: 8911150
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacological characterization of antagonists of the C5a receptor.
    Paczkowski NJ; Finch AM; Whitmore JB; Short AJ; Wong AK; Monk PN; Cain SA; Fairlie DP; Taylor SM
    Br J Pharmacol; 1999 Dec; 128(7):1461-6. PubMed ID: 10602324
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 1,25(OH)2D3 and cAMP synergistically induce complement 5a receptor messenger RNA.
    Rubin J; Biskobing D; Titus L; Thornton DL; Catherwood BD; Nanes MS
    Am J Med Sci; 1996 Feb; 311(2):73-9. PubMed ID: 8615377
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of C5aR expression on human neutrophils by encapsulated and acapsular Cryptococcus neoformans.
    Monari C; Kozel TR; Bistoni F; Vecchiarelli A
    Infect Immun; 2002 Jul; 70(7):3363-70. PubMed ID: 12065474
    [TBL] [Abstract][Full Text] [Related]  

  • 58. C5a regulates NKT and NK cell functions in sepsis.
    Fusakio ME; Mohammed JP; Laumonnier Y; Hoebe K; Köhl J; Mattner J
    J Immunol; 2011 Dec; 187(11):5805-12. PubMed ID: 22058413
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A case of episodic angioedema associated with blood eosinophilia: upregulated C5a receptor expression on eosinophils.
    Nakashima K; Sakurada T; Imayama S; Masukawa S; Ember JA; Hugli TE; Abe M
    Allergy; 1998 Mar; 53(3):320-3. PubMed ID: 9542615
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation.
    Mollnes TE; Brekke OL; Fung M; Fure H; Christiansen D; Bergseth G; Videm V; Lappegård KT; Köhl J; Lambris JD
    Blood; 2002 Sep; 100(5):1869-77. PubMed ID: 12176911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.